Key facts
- It has raised $2.1M; the latest was Accelerator/Incubator ($10K) in May 2025.
- Notable investors include Climate Capital, EIT Food, 7Cap Investments, Ananda Impact Ventures, CDTM Ventures — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Differential Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Differential Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Differential Bio
Developer of a virtual scale-up platform designed to assist in microbial growth prediction and process development through bioprocess optimization. The company's platform uses robotic lab automation and AI-driven insights to simulate, optimize, and accelerate bioprocesses, enabling businesses to optimize microbial growth conditions and deliver fast and cost-effective systems for scalable fermentation outcomes.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2023
- Employees
- 10
- Website
- differential.bio/
- Ownership
- Privately Held (backing)
Differential Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Differential Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Differential Bio in its N-PORT filings yet. We sweep new filings monthly.